Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (321-330 of 651) with videos related to

Pageof 66
Sort By:
Haematologica|November 20, 2025
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplicationSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Leukemia & Lymphoma|January 21, 2012
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphomaNils H Thoennissen, Gabriela B Thoennissen, Sam Abbassi, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Blood|August 27, 2013
Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemiaChristiane Katzerke, Vikas Madan, Dennis Gerloff, et al.
Mycoses|November 6, 2009
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patientsMaria J G T Rüping, Carsten Müller, Jörg J Vehreschild, et al.
Clinical Epigenetics|October 5, 2018
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDsLaurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
AI-Based 3D-Segmentation Quantifies Sarcopenia in Multiple Myeloma PatientsThuy-Duong Do, Tobias Nonnenmacher, Marieke Burghardt, et al.
Blood Advances|March 20, 2026
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantationJake Tobin, Patrick Stelmach, Sarah Richter, et al.
Cancer Research|November 4, 2005
Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformationChristian H Brandts, Bülent Sargin, Miriam Rode, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 27, 2015
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue FactorCaroline Brand, Stefanie Dencks, Georg Schmitz, et al.
Pageof 66

Showing results (321-330 of 651) with videos related to

Sort By:
Pageof 66
Haematologica|November 20, 2025
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplicationSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Leukemia & Lymphoma|January 21, 2012
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphomaNils H Thoennissen, Gabriela B Thoennissen, Sam Abbassi, et al.
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Blood|August 27, 2013
Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemiaChristiane Katzerke, Vikas Madan, Dennis Gerloff, et al.
Mycoses|November 6, 2009
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patientsMaria J G T Rüping, Carsten Müller, Jörg J Vehreschild, et al.
Clinical Epigenetics|October 5, 2018
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDsLaurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
AI-Based 3D-Segmentation Quantifies Sarcopenia in Multiple Myeloma PatientsThuy-Duong Do, Tobias Nonnenmacher, Marieke Burghardt, et al.
Blood Advances|March 20, 2026
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantationJake Tobin, Patrick Stelmach, Sarah Richter, et al.
Cancer Research|November 4, 2005
Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformationChristian H Brandts, Bülent Sargin, Miriam Rode, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 27, 2015
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue FactorCaroline Brand, Stefanie Dencks, Georg Schmitz, et al.
Pageof 66